164 related articles for article (PubMed ID: 37886527)
1. A modular microfluidic platform to study how fluid shear stress alters estrogen receptor phenotype in ER
Quesada BAO; Cuccia J; Coates R; Nassar B; Littlefield E; Martin EC; Melvin AT
Res Sq; 2023 Oct; ():. PubMed ID: 37886527
[TBL] [Abstract][Full Text] [Related]
2. A modular microfluidic platform to study how fluid shear stress alters estrogen receptor phenotype in ER
Ortega Quesada BA; Cuccia J; Coates R; Nassar B; Littlefield E; Martin EC; Melvin AT
Microsyst Nanoeng; 2024; 10():25. PubMed ID: 38370397
[TBL] [Abstract][Full Text] [Related]
3. Fluid shear stress in a logarithmic microfluidic device enhances cancer cell stemness marker expression.
Dash SK; Patra B; Sharma V; Das SK; Verma RS
Lab Chip; 2022 May; 22(11):2200-2211. PubMed ID: 35544034
[TBL] [Abstract][Full Text] [Related]
4. Responses of Cellular Adhesion Strength and Stiffness to Fluid Shear Stress during Tumor Cell Rolling Motion.
Li W; Mao S; Khan M; Zhang Q; Huang Q; Feng S; Lin JM
ACS Sens; 2019 Jun; 4(6):1710-1715. PubMed ID: 31094503
[TBL] [Abstract][Full Text] [Related]
5. Biophysical analysis of fluid shear stress induced cellular deformation in a microfluidic device.
Landwehr GM; Kristof AJ; Rahman SM; Pettigrew JH; Coates R; Balhoff JB; Triantafillu UL; Kim Y; Melvin AT
Biomicrofluidics; 2018 Sep; 12(5):054109. PubMed ID: 30364235
[TBL] [Abstract][Full Text] [Related]
6. Hele Shaw microfluidic device: A new tool for systematic investigation into the effect of the fluid shear stress for organs-on-chips.
Delon LC; Guo Z; Kashani MN; Yang CT; Prestidge C; Thierry B
MethodsX; 2020; 7():100980. PubMed ID: 32685381
[TBL] [Abstract][Full Text] [Related]
7. Online Analysis of Drug Toxicity to Cells with Shear Stress on an Integrated Microfluidic Chip.
Feng S; Mao S; Zhang Q; Li W; Lin JM
ACS Sens; 2019 Feb; 4(2):521-527. PubMed ID: 30688066
[TBL] [Abstract][Full Text] [Related]
8. Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression.
Bowers LW; Cavazos DA; Maximo IX; Brenner AJ; Hursting SD; deGraffenried LA
Breast Cancer Res; 2013; 15(4):R59. PubMed ID: 23880059
[TBL] [Abstract][Full Text] [Related]
9. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
[TBL] [Abstract][Full Text] [Related]
10. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
Siraj MA; Jacobs AT; Tan GT
Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
[TBL] [Abstract][Full Text] [Related]
11. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC
Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335
[TBL] [Abstract][Full Text] [Related]
12. Alterations in cancer cell mechanical properties after fluid shear stress exposure: a micropipette aspiration study.
Chivukula VK; Krog BL; Nauseef JT; Henry MD; Vigmostad SC
Cell Health Cytoskelet; 2015 Jan; 7():25-35. PubMed ID: 25908902
[TBL] [Abstract][Full Text] [Related]
13. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
[TBL] [Abstract][Full Text] [Related]
14. Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling.
Tohkayomatee R; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
Molecules; 2022 May; 27(11):. PubMed ID: 35684480
[TBL] [Abstract][Full Text] [Related]
15. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
16. A microfluidic-based multi-shear device for investigating the effects of low fluid-induced stresses on osteoblasts.
Yu W; Qu H; Hu G; Zhang Q; Song K; Guan H; Liu T; Qin J
PLoS One; 2014; 9(2):e89966. PubMed ID: 24587156
[TBL] [Abstract][Full Text] [Related]
17. Fluid shear stress induces cancer stem cell-like phenotype in MCF7 breast cancer cell line without inducing epithelial to mesenchymal transition.
Triantafillu UL; Park S; Klaassen NL; Raddatz AD; Kim Y
Int J Oncol; 2017 Mar; 50(3):993-1001. PubMed ID: 28197635
[TBL] [Abstract][Full Text] [Related]
18. Heregulin controls ERα and HER2 signaling in mammospheres of ERα-positive breast cancer cells and interferes with the efficacy of molecular targeted therapy.
Fukui F; Hayashi SI; Yamaguchi Y
J Steroid Biochem Mol Biol; 2020 Jul; 201():105698. PubMed ID: 32404282
[TBL] [Abstract][Full Text] [Related]
19. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
20. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
